Technology Validated by Global Medical Leaders
Technology Validated by Global Medical Leaders
ASX Announcements
Thu, 30 Apr 2026 Quarterly Activities & Cashflow Report Mon, 27 Apr 2026 Change of Director's Interest Notice TC DH SR Mon, 27 Apr 2026 Notification regarding unquoted securities - HMD Mon, 27 Apr 2026 Notification regarding unquoted securities - HMD Tue, 21 Apr 2026 Letter to Shareholders, Notice of AGM & Proxy Form Fri, 10 Apr 2026 Notification regarding unquoted securities - HMD Fri, 10 Apr 2026 Change of Director's Interest Notice - SR Thu, 02 Apr 2026 Cleansing Notice Thu, 02 Apr 2026 Application for quotation of securities - HMD Mon, 30 Mar 2026 Notification of Date of AGM Thu, 26 Mar 2026 Results of Meeting Mon, 16 Mar 2026 Change of Director's Interest Notice - AG Thu, 12 Mar 2026 Cleansing Notice Thu, 12 Mar 2026 Application for quotation of securities - HMD Fri, 27 Feb 2026 Appendix 4G and Corporate Governance Statement Fri, 27 Feb 2026 Annual Report to shareholders Fri, 27 Feb 2026 Preliminary Final Report Thu, 26 Feb 2026 Investor Presentation Tue, 24 Feb 2026 Letter to Shareholders, Notice of EGM & Proxy Form Tue, 10 Feb 2026 Dr Adam Myers- Chair of Commercial Scientific Advisory Board Wed, 04 Feb 2026 Application for quotation of securities - HMD Wed, 04 Feb 2026 Cleansing Notice Wed, 04 Feb 2026 Application for quotation of securities - HMD Fri, 30 Jan 2026 Quarterly Activities & Cashflow Report Tue, 27 Jan 2026 Proposed issue of securities - HMD Tue, 27 Jan 2026 Proposed issue of securities - HMD Tue, 27 Jan 2026 HeraMED completes $3.2 million placement Thu, 22 Jan 2026 Trading Halt Mon, 05 Jan 2026 CHANGE OF AUDITOR & APPOINTMENT OF JOINT COMPANY SECRETARY Tue, 23 Dec 2025 Application for quotation of securities - HMD Tue, 02 Dec 2025 HeraMED Investor Update Webinar Fri, 28 Nov 2025 Application for quotation of securities - HMD Thu, 27 Nov 2025 HeraMED partners with Lee Health- digital maternity solution Tue, 25 Nov 2025 HeraMED partners with Philips for US maternity solution Fri, 21 Nov 2025 Trading Halt Fri, 21 Nov 2025 Pause in Trading Thu, 20 Nov 2025 HeraBEAT receives upgraded TGA regulatory classification Fri, 14 Nov 2025 Change of address Fri, 31 Oct 2025 Quarterly Activities & Cashflow Report Tue, 21 Oct 2025 Application for quotation of securities - HMD Fri, 17 Oct 2025 Initial Director's Interest Notice Fri, 17 Oct 2025 Appointment of Non-Executive Director - Dr Sharon R. Howell Mon, 22 Sept 2025 HeraMED accelerates its next generation AI roadmap Thu, 28 Aug 2025 Appendix 4D and Half Year Report Thu, 21 Aug 2025 Ceasing to be a substantial holder Fri, 15 Aug 2025 Application for quotation of securities - HMD Wed, 13 Aug 2025 Cleansing Notice Wed, 13 Aug 2025 Notification regarding unquoted securities - HMD Wed, 13 Aug 2025 Application for quotation of securities - HMD Tue, 05 Aug 2025 Reinstatement to Quotation Mon, 04 Aug 2025 Proposed issue of securities - HMD Mon, 04 Aug 2025 Proposed issue of securities - HMD Mon, 04 Aug 2025 Quarterly Activities & Cashflow Report Mon, 04 Aug 2025 HeraMED completes $1.98 million placement Fri, 01 Aug 2025 Suspension from Quotation Thu, 31 July 2025 Trading Halt Thu, 31 July 2025 Pause in Trading Mon, 14 July 2025 Notification regarding unquoted securities - HMD Mon, 14 July 2025 Notification of cessation of securities - HMD Mon, 16 June 2025 Grant Awarded to Advance AI Maternity Care with RMIT & DHCRC Mon, 02 June 2025 Replacement Constitution Thu, 29 May 2025 Results of Meeting Mon, 19 May 2025 Customer Update & US Market Strategy Thu, 15 May 2025 Trading Halt Thu, 15 May 2025 Pause in Trading Wed, 30 Apr 2025 Quarterly Activities & Cashflow Report Mon, 28 Apr 2025 Letter to Shareholders, Notice of AGM & Proxy Form Mon, 07 Apr 2025 Notification of Date of AGM Tue, 18 Mar 2025 HeraMED to present at NWR Virtual Healthcare Conference Fri, 28 Feb 2025 Appendix 4G and Corporate Governance Statement Fri, 28 Feb 2025 Annual Report to shareholders Fri, 28 Feb 2025 Preliminary Final Report Tue, 25 Feb 2025 Strategic Collaboration Agreement with Garmin Health Wed, 19 Feb 2025 Investor presentation Tue, 18 Feb 2025 Change of Director's Interest Notice - AG Tue, 18 Feb 2025 Notification regarding unquoted securities - HMD Fri, 31 Jan 2025 Quarterly Activities & Cashflow Report Tue, 31 Dec 2024 Ceasing to be a substantial holder Tue, 24 Dec 2024 Notification regarding unquoted securities - HMD Tue, 24 Dec 2024 Application for quotation of securities - HMD Tue, 24 Dec 2024 Application for quotation of securities - HMD Mon, 23 Dec 2024 Extension of Prospectus Closing Date Fri, 20 Dec 2024 Cleansing Prospectus Thu, 19 Dec 2024 Results of Meeting Tue, 17 Dec 2024 Healthcare Technology Expert Advisory Board Appointment Wed, 04 Dec 2024 Investor presentation Tue, 26 Nov 2024 LOI with Metronomic to develop postpartum care in US Wed, 20 Nov 2024 Letter to Shareholders/Notice of General Meeting/Proxy Form Mon, 11 Nov 2024 Proposed issue of securities - HMD Mon, 11 Nov 2024 HeraMED completes further $1million placement Tue, 29 Oct 2024 Application for quotation of securities - HMD Tue, 29 Oct 2024 Cleansing Prospectus Tue, 29 Oct 2024 Quarterly Activities & Cashflow Report Wed, 23 Oct 2024 Proposed issue of securities - HMD Wed, 23 Oct 2024 Proposed issue of securities - HMD Wed, 23 Oct 2024 HeraMED completes $3.1 million placement Mon, 21 Oct 2024 Trading Halt Mon, 21 Oct 2024 Pause in Trading Tue, 08 Oct 2024 HeraCARE user growth continues to rise Fri, 04 Oct 2024 Notification of cessation of securities - HMD Fri, 27 Sept 2024 HeraBEAT TGA regulatory classification to be upgraded Mon, 23 Sept 2024 Letter of Intent with Founda Health Wed, 28 Aug 2024 Appendix 4D and Half Year Report Mon, 12 Aug 2024 Change of Registry Address Tue, 30 July 2024 Quarterly Activities & Cashflow Report Tue, 23 July 2024 Update to Managing Director & CEO Remuneration Package Mon, 15 July 2024 UTS Strategic Partnership Thu, 04 July 2024 Becoming a substantial holder Fri, 28 June 2024 Becoming a substantial holder Fri, 28 June 2024 Change of Director's Interest Notice AG DH TC Wed, 26 June 2024 Notification regarding unquoted securities - HMD Wed, 26 June 2024 Notification regarding unquoted securities - HMD Wed, 26 June 2024 Application for quotation of securities - HMD Tue, 25 June 2024 Target Market Determination - Options Tue, 25 June 2024 Cleansing and Options Prospectus Tue, 25 June 2024 Notification of cessation of securities - HMD Mon, 24 June 2024 Telstra Health soft launch HeraCARE Thu, 20 June 2024 Results of Meeting Thu, 20 June 2024 2024 Annual General Meeting Address Wed, 19 June 2024 HeraCARE Platform Records Highest Number of Active Mums Mon, 17 June 2024 HeraCARE live at Broward Health, USA Tue, 11 June 2024 Termination of Fembridge Partnership Thu, 06 June 2024 Trading Halt Thu, 06 June 2024 Pause in Trading Fri, 24 May 2024 Application for quotation of securities - HMD Wed, 22 May 2024 Proposed issue of securities - HMD Wed, 22 May 2024 Application for quotation of securities - HMD Wed, 22 May 2024 Addendum to AGM Notice of Meeting Mon, 20 May 2024 Change of Auditor Fri, 17 May 2024 Initial Director's Interest Notice - AG Mon, 13 May 2024 Reinstatement to Quotation Fri, 10 May 2024 Strategic Review, New Leadership & Successful Capital Raise Fri, 10 May 2024 Proposed issue of securities - HMD Fri, 10 May 2024 Quarterly Activities & Cashflow Report Thu, 09 May 2024 Extension of Voluntary Suspension Wed, 08 May 2024 ASIC Approval for Extension to Hold 2024 AGM Fri, 03 May 2024 Final Director's Interest Notice - RW Wed, 01 May 2024 Non-Executive Director resignation Tue, 30 Apr 2024 Notice of Annual General Meeting/Proxy Form Mon, 29 Apr 2024 Extension of Voluntary Suspension Fri, 19 Apr 2024 Response to ASX Appendix 3Y Query Fri, 19 Apr 2024 Change of Company Registered Address Wed, 10 Apr 2024 Correction - Change of Director's Interest Notice - DH Wed, 10 Apr 2024 Date of AGM and Closing Date for Director Nominations Tue, 09 Apr 2024 Change of Leadership & Company Secretary Mon, 08 Apr 2024 Supplemental Information - Voluntary Suspension Fri, 05 Apr 2024 Suspension from Quotation Wed, 03 Apr 2024 Trading Halt Wed, 03 Apr 2024 Pause in Trading Thu, 28 Mar 2024 Annual Report to shareholders Thu, 28 Mar 2024 Change of Director's Interest Notice Thu, 28 Mar 2024 Appendix 4G and Corporate Governance Statement Wed, 13 Mar 2024 Binding Strategic Partnership Agreement signed US FemBridge Mon, 11 Mar 2024 Initial Director's Interest Notice Mon, 11 Mar 2024 Final Director's Interest Notice Mon, 11 Mar 2024 Board Changes Mon, 11 Mar 2024 Notification regarding unquoted securities - HMD Fri, 08 Mar 2024 Change of Share Registry Fri, 01 Mar 2024 Cleansing Notice Fri, 01 Mar 2024 Application for quotation of securities - HMD Thu, 29 Feb 2024 Appendix 4E & Preliminary Final Report Wed, 28 Feb 2024 Application for quotation of securities - HMD Wed, 28 Feb 2024 Results of Rights Issue and Placement Update Wed, 28 Feb 2024 Reinstatement to Quotation Wed, 28 Feb 2024 Broward Health signs 2 year agreement for rollout HeraCARE Mon, 26 Feb 2024 Suspension from Official Quotation Fri, 23 Feb 2024 Results of Meeting Thu, 22 Feb 2024 Trading Halt Thu, 22 Feb 2024 Pause in Trading Fri, 02 Feb 2024 Update - Proposed issue of securities - HMD Thu, 01 Feb 2024 Extension of Entitlement Offer Closing Date Wed, 31 Jan 2024 Quarterly Activities & Cashflow Report Mon, 29 Jan 2024 HMD Entitlement Offer - Notification Ineligible Shareholders Mon, 29 Jan 2024 Despatch of Rights Issue Offer Materials Thu, 25 Jan 2024 Notice of General Meeting/Proxy Form Tue, 23 Jan 2024 Notification regarding unquoted securities - HMD Mon, 22 Jan 2024 Collaboration signed - leading obstetricians and physician Thu, 18 Jan 2024 Non-Renounceable Issue Thu, 18 Jan 2024 Proposed issue of securities - HMD Thu, 18 Jan 2024 Cleansing Notice Wed, 17 Jan 2024 Final Director's Interest Notice Emily Slade Wed, 17 Jan 2024 Non-Executive Director Resignation Tue, 16 Jan 2024 Strategic collaboration and commercial agreement with GPEx Fri, 22 Dec 2023 Cleansing Notice Fri, 22 Dec 2023 Application for quotation of securities - HMD Tue, 19 Dec 2023 Notification regarding unquoted securities - HMD Tue, 19 Dec 2023 USA-based Wingwomen signs MoU - launch 'Cardio Care' Mon, 18 Dec 2023 MOU signed with US-based FemBridge - maternity care solution Fri, 15 Dec 2023 Proposed issue of securities - HMD Fri, 15 Dec 2023 Placement completed successfully raising $1.25 million Wed, 13 Dec 2023 Trading Halt Tue, 21 Nov 2023 Signed Partner Agreement with Telstra Health Wed, 08 Nov 2023 Clinical Trial launched at Gold Coast Hospital Wed, 08 Nov 2023 Final Director's Interest Notice Wed, 08 Nov 2023 Resignation of CEO & MD and appointment new CFO Tue, 31 Oct 2023 Quarterly Activities & Cashflow Report Mon, 09 Oct 2023 Change of Director's Interest Notice - Ron W Mon, 09 Oct 2023 Notification regarding unquoted securities - HMD Tue, 19 Sept 2023 Results of Meeting Fri, 18 Aug 2023 Appendix 4D and Half Year Report Mon, 14 Aug 2023 Notice of General Meeting/Proxy Form Mon, 31 July 2023 Quarterly Activities & Cashflow Report Mon, 31 July 2023 New Appointments to Strengthen USA Commercialisation Fri, 21 July 2023 Notification regarding unquoted securities - HMD Thu, 20 July 2023 Cleansing Notice Thu, 20 July 2023 Application for quotation of securities - HMD Wed, 12 July 2023 Proposed issue of securities - HMD Wed, 12 July 2023 HeraMED completes AU$2.58 million Private Placement Mon, 10 July 2023 Trading Halt Fri, 07 July 2023 Investor Presentation July 2023 Mon, 03 July 2023 Dr Ron Weinberger appointed Executive Chairman - Updated Mon, 03 July 2023 Dr Ron Weinberger appointed Executive Chairman Thu, 15 June 2023 E-Lovu signs first 3 year commercial agreement Tue, 06 June 2023 Further information - Strategic Partnership Rewards Platform Mon, 05 June 2023 Trading Halt Thu, 01 June 2023 Strategic Partnership signed - US employee rewards platform Tue, 30 May 2023 Results of Annual General Meeting Thu, 11 May 2023 Contract signed with private Obstetrics & Gynaecology Group Fri, 28 Apr 2023 Notice of Annual General Meeting/Proxy Form Fri, 28 Apr 2023 Quarterly Activities & Cashflow Report Mon, 24 Apr 2023 Final Director's Interest Notice Thu, 20 Apr 2023 Board & Management changes Fri, 14 Apr 2023 Date of AGM and Closing Date for Director Nominations Mon, 27 Mar 2023 Change of Director's Interest Notice Thu, 23 Mar 2023 Appendix 4G and Corporate Governance Statement Thu, 23 Mar 2023 Annual Report to shareholders Tue, 21 Mar 2023 Gold Coast Hospital to begin trial of the HeraCARE Platform Wed, 01 Mar 2023 Appendix 2A Wed, 01 Mar 2023 Cleansing Prospectus Wed, 01 Mar 2023 Proposed issue of securities - HMD Tue, 28 Feb 2023 Appendix 4E & Preliminary Final Report Mon, 20 Feb 2023 Successful First Phase - e-Lovu Initial Commercial Rollout Wed, 08 Feb 2023 Distribution Schedule Wed, 08 Feb 2023 Top 20 securityholders Thu, 02 Feb 2023 Results of Meeting Tue, 31 Jan 2023 Quarterly Activities & Cashflow Report Fri, 27 Jan 2023 Notification regarding unquoted securities - HMD Tue, 24 Jan 2023 Appointment of Keith Koby as President, North America Mon, 23 Jan 2023 HMD - Securities Trading Policy Mon, 16 Jan 2023 Correction - Notice of General Meeting Thu, 29 Dec 2022 Notice of General Meeting Wed, 23 Nov 2022 Ramsay Affiliated Melbourne Mothers Practice Adopts HeraCARE Tue, 08 Nov 2022 JHCs Clinical Trial Published in Nature Portfolio Fri, 28 Oct 2022 Quarterly Activities & Cashflow Report Tue, 25 Oct 2022 Notification regarding unquoted securities - HMD Tue, 25 Oct 2022 Notification regarding unquoted securities - HMD Tue, 25 Oct 2022 Notification regarding unquoted securities - HMD Tue, 25 Oct 2022 Cleansing Notice Tue, 25 Oct 2022 Application for quotation of securities - HMD Wed, 12 Oct 2022 Results of Annual General Meeting Tue, 13 Sept 2022 Initial Director's Interest Notice - Emily Slade Tue, 13 Sept 2022 Appointment of Emily Slade as a Non-Executive Director Fri, 09 Sept 2022 Notice of Annual General Meeting/Proxy Form Wed, 31 Aug 2022 Cleansing Notice Wed, 31 Aug 2022 Application for quotation of securities - HMD Fri, 26 Aug 2022 Appendix 4D and Half Year Report Wed, 24 Aug 2022 Proposed issue of securities - HMD Wed, 24 Aug 2022 HeraMED Completes $4 Million Private Placement Mon, 22 Aug 2022 Trading Halt Thu, 18 Aug 2022 Notification of cessation of securities - HMD Tue, 16 Aug 2022 Notification of cessation of securities - HMD Tue, 02 Aug 2022 Notification regarding unquoted securities - HMD Fri, 29 July 2022 Quarterly Activities & Cashflow Report Thu, 28 July 2022 HMD & e-Lovu Health Partnership for HeraCARE Deployment US Tue, 26 July 2022 Notification of cessation of securities - HMD Tue, 26 July 2022 HMD Appoints New Head of ANZ Strategic Partnerships Tue, 19 July 2022 Sheba HeraBEAT Clinical Trial Completed - Excellent Results Mon, 18 July 2022 HMD Part of Team Providing Telemedicine Solutions West Bank Fri, 08 July 2022 Notification of cessation of securities - HMD Tue, 07 June 2022 Notification regarding unquoted securities - HMD Thu, 05 May 2022 Notification regarding unquoted securities - HMD Wed, 04 May 2022 Notification regarding unquoted securities - HMD Mon, 02 May 2022 Outstanding Results Achieved in Second JHC Clinical Trial Fri, 29 Apr 2022 Cleansing Notice Fri, 29 Apr 2022 Application for quotation of securities - HMD Fri, 29 Apr 2022 Quarterly Activities & Cashflow Report Tue, 26 Apr 2022 Investor Presentation - April 2022 Tue, 19 Apr 2022 HMD-Pediatrix Virtual OB Pilot Shows Promising Results Tue, 29 Mar 2022 Appendix 4G and Corporate Governance Statement Tue, 29 Mar 2022 Annual Report to shareholders Tue, 01 Mar 2022 Notification of cessation of securities - HMD Fri, 25 Feb 2022 Appendix 4E & Preliminary Final Report Fri, 25 Feb 2022 Notification of cessation of securities - HMD Mon, 21 Feb 2022 Cleansing Notice Mon, 21 Feb 2022 Application for quotation of securities - HMD Mon, 31 Jan 2022 Quarterly Activities & Cashflow Report Fri, 28 Jan 2022 Cleansing Notice Fri, 28 Jan 2022 Application for quotation of securities - HMD Fri, 21 Jan 2022 Reinstatement to Official Quotation Fri, 21 Jan 2022 JHC agrees to full commercial rollout of HeraCARE Thu, 20 Jan 2022 Suspension from Official Quotation Tue, 18 Jan 2022 Trading Halt Tue, 18 Jan 2022 Pause in Trading Mon, 20 Dec 2021 Results of Meeting Fri, 10 Dec 2021 Notification of cessation of securities - HMD Fri, 10 Dec 2021 Notification of cessation of securities - HMD Thu, 09 Dec 2021 Cleansing Notice Thu, 09 Dec 2021 Application for quotation of securities - HMD Tue, 07 Dec 2021 Change of Director's Interest Notice x 3 Tue, 07 Dec 2021 Cleansing Notice Tue, 07 Dec 2021 Application for quotation of securities - HMD Thu, 02 Dec 2021 Cleansing Notice Thu, 02 Dec 2021 Application for quotation of securities - HMD Thu, 02 Dec 2021 Positive Interim Results in HeraCARE Paid Pilot - Joondalup Thu, 18 Nov 2021 Notice of General Meeting/Proxy Form Mon, 15 Nov 2021 Update on Placement Capacity Mon, 15 Nov 2021 Response to ASX Price Query Fri, 29 Oct 2021 Cleansing Notice Fri, 29 Oct 2021 Quarterly Activities & Cashflow Report Thu, 28 Oct 2021 Appendix 3G Mon, 18 Oct 2021 Proposed issue of securities - HMD Mon, 18 Oct 2021 $2.39 million raised via a Convertible Note Thu, 14 Oct 2021 Trading Halt Mon, 13 Sept 2021 Positive Interim Results US Paid Pilot & 2nd Site Confirmed Wed, 01 Sept 2021 HeraCARE Shortlisted for Government tender in Spain Fri, 27 Aug 2021 Appendix 4D and Half Year Report Mon, 16 Aug 2021 Cleansing Prospectus Fri, 13 Aug 2021 HeraCARE paid pilot commences at Joondalup Health Campus Mon, 02 Aug 2021 Sheba Expands Pilot to include High-Risk Pregnancies Thu, 29 July 2021 Quarterly Activities & Cashflow Report Fri, 23 July 2021 Results of Meeting Mon, 19 July 2021 Change of Registered Office Mon, 19 July 2021 Update - Notice of Extraordinary General Meeting Mon, 19 July 2021 HeraCARE paid pilot commences with US-based Obstetrix Group Wed, 14 July 2021 Application for quotation of securities - HMD Wed, 30 June 2021 Application for quotation of securities - HMD Wed, 23 June 2021 Notice of Extraordinary General Meeting/Proxy Form Tue, 15 June 2021 Notification regarding unquoted securities - HMD Tue, 15 June 2021 Appendix 3G Mon, 31 May 2021 Results of Annual General Meeting Mon, 31 May 2021 Chairman's letter to shareholders Mon, 17 May 2021 Updated Investor Presentation and Webinar Thu, 13 May 2021 Pilot agreement signed with US leader Obstetrix Medical Tue, 11 May 2021 Trading Halt Mon, 03 May 2021 Appendix 2A Thu, 29 Apr 2021 Notice of Annual General Meeting/Proxy Form Wed, 28 Apr 2021 Quarterly Activities & Cashflow Report Thu, 22 Apr 2021 HeraCARE commercial agreement with Joondalup Health Campus Tue, 20 Apr 2021 Trading Halt Mon, 29 Mar 2021 Appendix 4G and Corporate Governance Statement Mon, 29 Mar 2021 Annual Report to shareholders Tue, 16 Mar 2021 JHC's Study Published One of Most Cited Scientific Journals Fri, 26 Feb 2021 Appendix 4E & Preliminary Final Report Fri, 19 Feb 2021 Becoming a substantial holder Wed, 10 Feb 2021 Appendix 2A & Cleansing Notice Mon, 08 Feb 2021 Israel's Largest Healthcare Provider Begins Pilot Study Thu, 04 Feb 2021 Proposed issue of Securities - HMD Thu, 04 Feb 2021 Proposed issue of Securities - HMD Thu, 04 Feb 2021 Completion of AUD 2.3M Placement Tue, 02 Feb 2021 Trading Halt Fri, 29 Jan 2021 Quarterly Activities & Cashflow Report Wed, 27 Jan 2021 Hapvida Extends Subscription on new SaaS Terms
